Oncolytics Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.About ONCY
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
ONCY Key Statistics
Stock Snapshot
As of today, Oncolytics Biotech(ONCY) shares are valued at $1.04. The company's market cap stands at 112.28M, with a P/E ratio of -3.70.
On 2025-12-17, Oncolytics Biotech(ONCY) stock moved within a range of $0.93 to $1.05. With shares now at $1.04, the stock is trading +11.8% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 1.06M, compared to an average daily volume of 655.28K.
The stock's 52-week range extends from a low of $0.33 to a high of $1.51.
The stock's 52-week range extends from a low of $0.33 to a high of $1.51.
ONCY News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Oncolytics (ONCY) announced clinical and translational findings supporting the development of pelareorep in second-line metastatic colorectal cancer, specifical...